What move does the options market price into Inhibrx Biosciences's report?

Implied ±8.1%, either direction.

How often does Inhibrx Biosciences move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

INBXNasdaqBiological Products, (No Diagnostic Substances)

Inhibrx Biosciences, Inc. (INBX) earnings date, market-implied expected move, and options open interest by expiry

84.59

+4.31 · +5.37%

post 84.60 +0.01%

After hours16:00 ETdelayed

Open81.79Volume242,327Mkt cap$1.2BEPS-8.88

Day81.48 – 84.60100%52-wk57.30 – 155.2928%

INBX

Inhibrx Biosciences, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±8.1%implied · report alone

8Q avg ±5.5%·×1.48·rich

76.6290.18

straddle ±13.9%

spot 83.40exp Nov 20ATM strike 85ATM straddle 13.60IV 103%

Nov 6 closereport share · term structure

Expected move

Inputs

Next report

Nov 13

after close · in 7 days

est.Q3 FY26

Calendar

Next report

Last report

−8.91%

vs ±11.9% implied · ×0.75

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Linked news

7dSNY · customerSanofi Q3 sales €14,444 million, business EPS €3.55; upgrades 2026 guidance
7dREGN · customerRegeneron reports Q3 net income $1,948.7 million, revenues $5,115.8 million

News

Largest filed tie

13F top-10 QoQ

+15.86%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

164 managers

Top fund weight

0.35%

INBX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Inhibrx Biosciences (INBX) is expected to report on Nov 13 after close (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±16.4%
avg realized: ±5.5%

Nov 14 '24Nov 14 '24confirmed±28.7%▼−3.49%×0.12

Mar 17 '25Mar 17 '25confirmed±27.8%▲+0.43%×0.02

May 14 '25May 14 '25confirmed±11.9%▲+10.89%×0.92

Aug 13 '25Aug 13 '25confirmed±18.9%▲+1.57%×0.08

Q3 FY25Nov 14 '25confirmed±18.3%▲+6.04%×0.33

Q1 FY26Mar 19 '26confirmed±6.5%▼−6.09%×0.94

May 14 '26May 14 '26confirmed±7.1%▼−6.47%×0.91

Q2 FY26Aug 13 '26confirmed±11.9%▼−8.91%×0.75

quarterimplied−30%0+30%realized×

Q2 FY26±11.9%▼−8.91%×0.75

May '26±7.1%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 4 close

0.43OI · 4 expiries · Nov 4 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

658+46%Nov 2014d1,527+19%

9—Dec 1842d0.5616+45%0.56

615−1%Jan 1570d0.154,131+2%0.15

21+31%Feb 19105d0.063440%0.06

ExpiryPutsCallsP/C

Nov 2014d658+46%1,527+19%0.43

Dec 1842d9—16+45%0.56

Jan 1570d615−1%4,131+2%0.15

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±13.9%

Funds 4

XBI±0.0%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

per later filingQ2 FY25

−2204.15%per later filingnet margin · revenue +1200.00% YoY

Revenue$1M—

Gross profit$1M100.00%—

Operating income−$27M−2106.85%+36.16%

Pre-tax income−$29M+33.85%

Net income−$29M−2204.15%+33.84%

Cost of revenue$0—

Operating expenses$29M−33.13%

Tax$2,000—

Other expense−$1M−208.05%

Source: SEC filings · standardized · QE Jun 30 '25 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 6 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

CPROF ×1.41· ±4.5% vs ±3.2% · 12 releases

eventrelease day|move|up · n×base

CPROFcorporate profits±4.5%9 of 12×1.41

CPIconsumer prices±4.2%5 of 10×1.31

GDPgross domestic product±4.0%12 of 19×1.25

PPIproducer prices±3.9%5 of 10×1.23

NFPjobs report±3.4%4 of 10×1.07

FOMCrate decision±3.1%7 of 19×0.98

PCEpersonal income & outlays±2.9%12 of 19×0.90

Bar = avg |move| to ±5% · tick = ±3.2% avg day · ×base = |move| ÷ ±3.2% · min 6 releases

Earnings history

EPS -2.34 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-2.34	—
Q1 FY26	Mar 19 '26 · confirmed	-2.15	—
Q3 FY25	Nov 14 '25 · confirmed	-2.28	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod